Sonoma Pharmaceuticals, Inc. (SNOA) stock
SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.01 (-0.76%)
Close on Nov 18, 2026Market cap $3.96MP/E –Yield –
Sonoma Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Sonoma Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $21.92M, up 47.0% year over year. For fiscal 2026 it was $19.53M, up 36.7% from the year before. Over ten years it grew 7.6% a year on average. The highest annual figure on record is $19.53M in fiscal 2026.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $19.53M | +36.7% |
| FY2025 | Mar 31, 2025 | $14.29M | +12.2% |
| FY2024 | Mar 31, 2024 | $12.74M | -4.0% |
| FY2023 | Mar 31, 2023 | $13.27M | +5.1% |
| FY2022 | Mar 31, 2022 | $12.63M | -32.2% |
| FY2021 | Mar 31, 2021 | $18.63M | +3.9% |
| FY2020 | Mar 31, 2020 | $17.93M | -5.5% |
| FY2019 | Mar 31, 2019 | $18.97M | +13.9% |
| FY2018 | Mar 31, 2018 | $16.66M | +29.9% |
| FY2017 | Mar 31, 2017 | $12.83M | +36.9% |
| FY2016 | Mar 31, 2016 | $9.37M | -32.4% |
| FY2015 | Mar 31, 2015 | $13.85M | +1.4% |
| FY2014 | Mar 31, 2014 | $13.67M | -11.5% |
| FY2013 | Mar 31, 2013 | $15.45M | +21.2% |
| FY2012 | Mar 31, 2012 | $12.74M | +30.7% |
| FY2011 | Mar 31, 2011 | $9.75M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $6.41M | +59.6% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $5.56M | +48.1% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $4.35M | +22.0% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $5.60M | +56.6% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $4.02M | +18.4% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $3.75M | +9.2% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $3.56M | +13.6% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $3.58M | +31.1% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $3.39M | -1.1% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $3.44M | +14.1% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $3.14M | +6.6% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $2.73M | -18.0% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $3.43M | -14.0% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $3.01M | +31.2% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $2.94M | +1.4% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $3.33M | -11.0% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $3.98M | +8.1% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $2.30M | +6.5% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $2.90M | -41.2% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $3.74M | -35.1% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $3.68M | -36.1% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $2.16M | -50.0% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $4.94M | +12.3% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $5.77M | +22.0% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $5.77M | +28.3% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $4.31M | -1.6% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $4.40M | -16.8% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $4.73M | -4.3% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $4.50M | +2.9% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $4.38M | +19.9% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $5.28M | +9.0% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $4.94M | +14.2% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $4.37M | +13.9% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $3.66M | -9.3% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $4.84M | +44.1% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $4.33M | +54.6% |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $3.84M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $4.03M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $3.36M | – |
| Q2 FY2017CQ3 2016 | Sep 30, 2016 | $2.80M | – |
See a number that looks wrong?